Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z8KU
|
|||
| Drug Name |
SGN-2FF
|
|||
| Synonyms |
IRKXGKIPOMIQOD-MDMQIMBFSA-N; ZINC95921490; 2,6-Dideoxy-2-fluoro-L-galactopyranose (alpha,beta Mixture); 74554-11-3
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | Phase 1 | [1] | |
| Company |
Seattle Genetics Bothell, WA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H11FO4
|
|||
| Canonical SMILES |
CC1C(C(C(C(O1)O)F)O)O
|
|||
| InChI |
1S/C6H11FO4/c1-2-4(8)5(9)3(7)6(10)11-2/h2-6,8-10H,1H3/t2-,3-,4+,5-,6?/m0/s1
|
|||
| InChIKey |
IRKXGKIPOMIQOD-ZZWDRFIYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.